Peer-to-Peer: Ivan Damjanov in Conversation with Markku Martti Miettinen - Summary - MDSpire
Feature

Peer-to-Peer: Ivan Damjanov in Conversation with Markku Martti Miettinen

Finland's finest reflects on building a global reputation, pioneering tumor classification, and decades of discovery

Share

Markku Martti Miettinen is a prominent surgical pathologist at the National Cancer Institute (NCI) renowned for his expertise in gastrointestinal stromal and soft tissue tumors. With over 500 peer-reviewed articles and 73,000 citations, he has significantly influenced pathology. Inspired by early experiences in botany and pathology, he pursued medicine, transitioning to the US for advanced opportunities. Miettinen leads a research program and collaborates internationally, focusing on diagnosing and improving treatments for rare tumors.

Original Source(s)

Peer-to-Peer: Ivan Damjanov in Conversation with Markku Martti Miettinen

  • by Ivan Damjanov

  • April 22, 2026

Related Content

Combined Clavicle Model May Improve Age Estimates

Combined approach shows higher sensitivity than traditional thresholds for classifying legal adulthood.

When Training Ends, Stress Begins

The realities of responsibility, fatigue, and sustaining a long-term career in pathology

Updated CAP Protocols Explained

  • April 20, 2026

  • 3 min